CVA (Cerebrovascular Accident)NCT07425158
Differences in Treatment Characteristics and Patient and Therapist Satisfaction Between Robot Assisted Therapy and Conventional Occupational Therapy Among Individuals Post Stroke
A study testing Robot Assisted Therapy (RAT) in people with CVA (Cerebrovascular Accident) and Stroke, run by linor kennet at 1 site in Israel.
Trial summary
The purpose of this study is to compare the differences in treatment characteristics and patient and therapist satisfaction, between Robot Assisted Therapy (RAT) and Conventional Occupational Therapy (COT) single session in individuals post stroke. Read more about this study
- Who is it for?
- Ages 18 to 85 years
- Conditions the study is for
- CVA (Cerebrovascular Accident), Stroke
- What is being tested?
- Robot Assisted Therapy (RAT)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteIsrael
- Study dates
- 1 Dec 2020to 1 Aug 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 to 85 year old following stroke (first-ever stroke).
- Individuals in the sub-acute phase (up to three months)
- Intact cognitive function (score > 21 points on the Mini Mental State Examination)
- Sever weakness of the affected upper limb (score 5-20 points on the FMA)
- Understanding and reading Hebrew
- Normal or corrected eyesight.
- Subjects were at least in one session of RAT and one session of COT
Who cannot join
- Neurological, cardio-vascular or orthopedic impairment, unrelated to the stroke, which restrict upper limb function.
- High muscle tone (score > 4 in Modified Ashworth Scale)
- Apraxia (score <68 in De Renzi Apraxia Test)
- Severe Sensory impairment.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to compare the differences in treatment characteristics and patient and therapist satisfaction, between Robot Assisted Therapy (RAT) and Conventional Occupational Therapy (COT) single session in individuals post stroke.
Read the detailed description
Method and research procedure: The study will include 30 sub-acute post stroke patients, aged 18-85, with severe motor impairment in the upper limb and with normal-mild cognitive ability, hospitalized at the Loewenstein Rehabilitation Hospital. Each subject will receive two 30-min treatment sessions, one Conventional Occupational Therapy (COT) and one Robot Assisted Therapy (RAT). Before and during each session, the Visual Analogue Scale (VAS) for reporting the level of pain will be administered. The number of repetitions and compensations will be counted by observation. After each session, a subjective satisfaction questionnaire regarding the treatment will be administered.
- Conditions
- CVA (Cerebrovascular Accident), Stroke
- Being tested
- Robot Assisted Therapy (RAT)
- Keywords
- Robot Assisted Therapy, Upper Extremity Paresis
- Medical subject headings
- Stroke, Paresis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Robot Assisted Therapy (RAT)Other
Also called Conventional occupational therapy (COT)
Robot Assisted Therapy (RAT): 30-min treatment session of active- assisted movements of shoulder and elbow, using a robotic arm and a computer screen, provides different exercises according to the motor ability of the patient. The robot provides proximal upper limb training in a three-dimensional (3D) environment. The occupational therapist will be planning the treatment by determining the range of motion, the amount of help and support and the level of difficulty of the game.
Conventional occupational therapy (COT): 30-min treatment session of active- assisted movements of the shoulder and elbow, using conventional facilities and devices. Treatment includes passive range of motion exercises and active- assistive exercises. The level of support and help will be determined by the occupational therapist.
| Study group | Role | What they receive |
|---|---|---|
| Therapy | Other | Each subject will receive two 30-min treatment sessions, one Robot Assisted Therapy and one Conventional Occupational Therapy. Receives: Other: Robot Assisted Therapy (RAT) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Observation
The number of repetitions and compensations will be counted by observation
Measured: 30 min
Secondary outcomes (2)
VAS
The Visual Analogue Scale (VAS) is a common scale for estimating pain level from one to ten.
Measured: 1min
Questionnaire
A subjective satisfaction questionnaire regarding the treatment will be administered.
Measured: 5 min
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2026
- Study start1 Dec 2020
- Primary completion1 Aug 2022
- Study completion1 Aug 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CVA (Cerebrovascular Accident)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- linor kennet
- Sponsor type
- University, hospital or other
- Collaborators
- Tel Aviv University
- Responsible party
- Sponsor-investigator, linor kennet, Loewenstein Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07425158
- Sponsor's protocol ID
- 0020-20-LOE
- Status last verified
- Feb 2026
- First submitted
- 16 Feb 2026
- Last updated
- 20 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Differences in Treatment Characteristics and Patient and Therapist Satisfaction Between Robot Assisted Therapy and Conventional Occupational Therapy Among Individuals Post Stroke
- ClinicalTrials.gov ID
- NCT07425158
- Acronym / sponsor ID
- 0020-20-LOE
- Conditions
- CVA (Cerebrovascular Accident), Stroke
- Keywords
- Robot Assisted Therapy, Upper Extremity Paresis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- linor kennetUniversity, hospital or other
- Collaborators
- Tel Aviv University
- Study start
- 1 Dec 2020 (actual)
- Primary completion
- 1 Aug 2022 (actual)
- Study completion
- 1 Aug 2022 (actual)
- First posted
- 20 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the differences in treatment characteristics and patient and therapist satisfaction, between Robot Assisted Therapy (RAT) and Conventional Occupational Therapy (COT) single session in individuals post stroke.
Detailed description
Method and research procedure: The study will include 30 sub-acute post stroke patients, aged 18-85, with severe motor impairment in the upper limb and with normal-mild cognitive ability, hospitalized at the Loewenstein Rehabilitation Hospital. Each subject will receive two 30-min treatment sessions, one Conventional Occupational Therapy (COT) and one Robot Assisted Therapy (RAT). Before and during each session, the Visual Analogue Scale (VAS) for reporting the level of pain will be administered. The number of repetitions and compensations will be counted by observation. After each session, a subjective satisfaction questionnaire regarding the treatment will be administered.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Therapy | Other | Other: Robot Assisted Therapy (RAT)Each subject will receive two 30-min treatment sessions, one Robot Assisted Therapy and one Conventional Occupational Therapy. |
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- 18 to 85 year old following stroke (first-ever stroke).
- Individuals in the sub-acute phase (up to three months)
- Intact cognitive function (score > 21 points on the Mini Mental State Examination)
- Sever weakness of the affected upper limb (score 5-20 points on the FMA)
- Understanding and reading Hebrew
Key exclusion criteria (4 listed)
- Neurological, cardio-vascular or orthopedic impairment, unrelated to the stroke, which restrict upper limb function.
- High muscle tone (score > 4 in Modified Ashworth Scale)
- Apraxia (score <68 in De Renzi Apraxia Test)
- Severe Sensory impairment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Robot Assisted Therapy (RAT)Also: Conventional occupational therapy (COT)Robot Assisted Therapy (RAT): 30-min treatment session of active- assisted movements of shoulder and elbow, using a robotic arm and a computer screen, provides different exercises according to the motor ability of the patient. The robot provides proximal upper limb training in a three-dimensional (3D) environment. The occupational therapist will be planning the treatment by determining the range of motion, the amount of help and support and the level of difficulty of the game. Conventional occupational therapy (COT): 30-min treatment session of active- assisted movements of the shoulder and elbow, using conventional facilities and devices. Treatment includes passive range of motion exercises and active- assistive exercises. The level of support and help will be determined by the occupational therapist. | Other | Therapy |
Primary outcome
Observation
Time frame: 30 min
The number of repetitions and compensations will be counted by observation
2 secondary outcomes
VAS
Time frame: 1min
Questionnaire
Time frame: 5 min
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2026.
Related trials for CVA (Cerebrovascular Accident)
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Robot Assisted Therapy (RAT) in people with CVA (Cerebrovascular Accident) and Stroke, run by linor kennet at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Observation (time frame: 30 min). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.